Early and remote detection is key

Alzheimer; News from the web:

Within a few years, doctors will be able to remotely evaluate patients for their risk of developing Alzheimer’s diseaseParkinson’s disease and frontotemporal dementia — without having to hook them up to expensive, cumbersome machines generally found only in hospitals. That’s the vision of Israeli entrepreneur Nathan Intrator, CEO of Neurosteer. “Millions of people suffer from neurodegenerative diseases, and as life expectancy goes up, that number will only increase,” 

Read all about it HERE